Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study

Chandan J. Vaidya1, Glenn Austin1, Gary Kirkorian1, Hugh W. Ridlehuber1, John E. Desmond1, Gary H. Glover1, John D. E. Gabrieli1
1Department of Psychology, Stanford University, Stanford, CA 94305; Community/Academia Coalition, 451 Cherry Lane, Los Altos, CA 94022; and Department of Radiology, Stanford University, Stanford, CA 94305

Tóm tắt

Functional MRI revealed differences between children with Attention Deficit Hyperactivity Disorder (ADHD) and healthy controls in their frontal–striatal function and its modulation by methylphenidate during response inhibition. Children performed two go/no-go tasks with and without drug. ADHD children had impaired inhibitory control on both tasks. Off-drug frontal–striatal activation during response inhibition differed between ADHD and healthy children: ADHD children had greater frontal activation on one task and reduced striatal activation on the other task. Drug effects differed between ADHD and healthy children: The drug improved response inhibition in both groups on one task and only in ADHD children on the other task. The drug modulated brain activation during response inhibition on only one task: It increased frontal activation to an equal extent in both groups. In contrast, it increased striatal activation in ADHD children but reduced it in healthy children. These results suggest that ADHD is characterized by atypical frontal–striatal function and that methylphenidate affects striatal activation differently in ADHD than in healthy children.

Từ khóa


Tài liệu tham khảo

R A Barkley Attention Deficit Hyperactivity Disorder: A Handbook For Diagnosis And Treatment (Guilford Press, New York, 1990).

10.1097/00004583-199709000-00014

10.1016/S0140-6736(97)11450-7

10.3109/10401239709147778

10.1001/archneur.1984.04050190031010

10.1001/archneur.1989.00520370050018

10.1097/00003072-199501000-00014

10.1056/NEJM199011153232001

10.1177/088307389601100210

10.1176/ajp.151.12.1791

10.1001/archpsyc.1996.01830070053009

10.1212/WNL.48.3.589

10.1177/088307389300800409

10.1001/archneur.1997.00550200027006

10.1523/JNEUROSCI.18-15-05901.1998

10.1016/S1054-3589(08)60730-9

10.1038/sj.mp.4000290

10.1038/sj.mp.4000354

10.1073/pnas.89.12.5675

10.1177/0883073891006001S13

10.1093/brain/119.1.191

10.1002/ana.410180518

10.1162/jocn.1997.9.6.835

Diagnostic and Statistical Manual of Mental Disorders (Am. Psychiatr. Assoc., 4th Ed., Washington, DC, 1994).

10.3928/0048-5713-19911201-08

10.1002/mrm.1910280204

J Talairach, P Tourneaux Co-Planar Stereotaxic Atlas of the Human Brain (Thieme, Stuttgart, 1988).

10.1002/(SICI)1097-0193(1997)5:1<58::AID-HBM6>3.0.CO;2-M

10.1097/00004728-199207000-00024

10.1002/hbm.460010207

H M Duvernoy The Human Brain: Surface Three-Dimensional Section Anatomy and MRI (Springer, New York, 1991).

S D Iverson, M Mishkin Exp Brain Res 11, 376–386 (1970).

10.1001/archpsyc.1989.01810060038007

10.1016/S0074-7742(08)60356-6

10.1097/00004583-199703000-00016

10.1523/JNEUROSCI.16-15-04816.1996

McDowell S. Whyte J. & D’Esposito M. (1998) Brain in press.

10.1176/ajp.154.1.50

10.1086/515485

10.1001/archpsyc.1980.01780210091010

D G Daniel, D R Weinberger, D W Jones, J R Zigun, R Coppola, S Handel, L B Bigelow, T E Goldberg, K F Berman, J E Kleinman J Neuropsychiatry Clin Neurosci 1, 377–384 (1991).

10.1037/1064-1297.5.1.3

C K Conners Conners Rating Scales: CPRS-39, CTRS-39 (Multi-Health Systems, North Tonawanda, NY, 1989).